Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




3D-Printing Technique Fabricates Microphysiological Devices

By HospiMedica International staff writers
Posted on 09 Nov 2016
Multi-material three-dimensional (3D) printing may one day be used to design organs-on-chips that match the properties of a specific disease, or even an individual patient’s cells.

Researchers at Harvard University (Cambridge, MA, USA) have developed a new technique to fabricate instrumented cardiac microphysiological devices (MPDs) that uses a mix of six functional inks that are based on piezo-resistive, high-conductance, biocompatible soft materials. More...
By using 3D printing, the researchers were able to print a physio-mimetic, laminar cardiac tissue MPD that integrates soft strain sensors into the micro-architecture of the tissue, all in a single, continuous procedure.

The chip contains multiple wells, each with separate tissues and integrated sensors, which allows the researchers to study many engineered cardiac tissues at once. To demonstrate the efficacy of the device, the researchers first validated that the embedded sensors provided non-invasive, electronic readouts of tissue contractile stresses inside cell incubator environments. They then used the MPD to study drug responses, as well as the contractile development of human stem cell-derived laminar cardiac tissues over four weeks. The study was published on October 24, 2016, in Nature Materials.

“Researchers are often left working in the dark when it comes to gradual changes that occur during cardiac tissue development and maturation, because there has been a lack of easy, non-invasive ways to measure the tissue functional performance,” said lead author Johan Ulrik Lind, PhD. “These integrated sensors allow researchers to continuously collect data while tissues mature and improve their contractility. Similarly, they will enable studies of gradual effects of chronic exposure to toxins.”

“Our microfabrication approach opens new avenues for in vitro tissue engineering, toxicology, and drug screening research,” said study co-author professor of bioengineering and applied physics Kit Parker, PhD. “Translating microphysiological devices into truly valuable platforms for studying human health and disease requires that we address both data acquisition and manufacturing of our devices. This work offers new potential solutions to both of these central challenges.”

MPDs, also known as organs-on-chips, mimic the structure and function of native tissue in-vitro and have emerged as a promising alternative to traditional animal testing; but the fabrication and data collection process is expensive and laborious. Currently, these devices are built in clean rooms using a complex, multi-step lithographic process, and collecting data requires microscopy or high-speed cameras, since they do not have integrated sensors.

Related Links:
Harvard University


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
ow Frequency Pulse Massager
ET10 L
Mobile X-Ray System
K4W
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.